Hyundai Bioscience’s niclosamide-based oral antiviral moves into Phase II, joining other Korean COVID-19 treatment candidates in the pivotal trial stages, while SK Bioscience’s Phase III recombinant protein vaccine gears up for global market entry.

Initiatives to promote information sharing and reliance among developing country regulators are bearing fruit in the Caribbean and Africa, although much works remains to be done, according to speakers at last week’s pre-ICDRA conference in Dublin.

The outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in South Korea is worsening, with the number of confirmed cases and fatalities continuing to climb. Struggling to contain the spread of the disease, the central government has announced it will step up efforts with provincial authorities, the private sector, the military and schools to ease the situation.

The outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in South Korea is worsening, with the number of confirmed cases and fatalities continuing to climb. Struggling to contain the spread of the disease, the central government has announced it will step up efforts with provincial authorities, the private sector, the military and schools to ease the situation.